Anti-eIF3A antibody [EPR5819(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Recombinant Monoclonal EIF3A antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 9 publications.
View Alternative Names
EIF3S10, KIAA0139, EIF3A, Eukaryotic translation initiation factor 3 subunit A, eIF3a, Eukaryotic translation initiation factor 3 subunit 10, eIF-3-theta, eIF3 p167, eIF3 p180, eIF3 p185
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-eIF3A antibody [EPR5819(2)] (AB128996)
ab128996, at 1/250 dilution, staining eIF3A in BxPC3 cells by Immunofluorescence.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF3A antibody [EPR5819(2)] (AB128996)
ab128996 at 1/50 dilution staining eIF3A in paraffin-embedded Human brain tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-eIF3A antibody [EPR5819(2)] (AB128996)
All lanes:
Western blot - Anti-eIF3A antibody [EPR5819(2)] (ab128996) at 1/1000 dilution
Lane 1:
BxPC-3 (Human pancreas adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 2:
293T (Human embryonic kidney epithelial cell) cell lysate at 10 µg
Lane 3:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 10 µg
Lane 4:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 5:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 6:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 7:
L6 (Rat skeletal muscle cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 166 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-eIF3A antibody [EPR5819(2)] (AB128996)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF3A is a central component of the eIF3 complex which consists of multiple subunits that interact to facilitate the beginning of translation. It supports the recruitment of mRNA to the small ribosomal subunit mediating the formation of the 43S pre-initiation complex. Its activity influences multiple downstream biological processes including cell growth and proliferation highlighting its essential role in maintaining normal cellular functions.
Pathways
EIF3A is integral to the mTOR signaling pathway which is important for regulating cell growth and protein synthesis. In this pathway eIF3A works closely with proteins like mTOR and Raptor interacting to control the translation initiation machinery. Additionally eIF3A contributes to the regulation of the Wnt signaling pathway which is important for cell proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:524 PubMed40346622
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 24:432 PubMed38589831
2024
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 12:e1075 PubMed36324258
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:794329 PubMed35300416
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:720619 PubMed34512348
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:11135-11149 PubMed33819187
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 44:2067-2079 PubMed33000235
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 9:2472-2479 PubMed30026845
2018
Applications
Unspecified application
Species
Unspecified reactive species
Neurobiology of disease 116:155-165 PubMed29792928
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com